View more in
Medical & Biotech

uniQure updates lead gene therapy’s timeline; acquires Corlieve to feed pipeline

MedCity News
 2021-06-22

Cover picture for the articleA hemophilia B gene therapy that uniQure is testing in a pivotal clinical trial is on track for a filing with the FDA early next year, an updated timeline that follows discussions with the agency about the data needed to support a submission seeking regulatory approval. Netherlands-based uniQure said Tuesday...

medcitynews.com

Comments / 0

Comments / 0